Spedra 200mg Reviews: Does It Work, and What Users Actually Report

• Publishes the regulator reported comparison that most pages leave out, including where avanafil came off worse
• Gives the 52 week adherence figures, so you can see how many men actually kept taking it
• States who funded the trials and who was studied, rather than presenting the results as universal
• States plainly why avanafil must never be combined with another erectile dysfunction medicine

Spedra 200mg works for many men and not for all of them, and the honest measure of that is published trial data rather than star ratings. This page carries no customer reviews, and that is deliberate.

Here is the short version of what the evidence shows. On the standard questionnaire used in the trials, avanafil 200mg improved erectile function scores by 9.4 points against 2.9 for placebo in a general population. In men with diabetes the same strength moved the score by 5.3 points. And in a 52 week study, only 21.5% of men were still taking it after a year, though very few stopped because of side effects.

That last figure is the one no review page will tell you, and it is more useful than any rating out of five.

One thing before the evidence. Spedra should not be taken with another erectile dysfunction medicine. The UK product information states that the safety and efficacy of combining avanafil with other PDE5 inhibitors or other erectile dysfunction treatments have not been studied, and patients should be advised not to use them together.

Spedra tablets are available in three doses: 50mg, 100mg, and 200mg. The recommended dose is usually 100mg, but your prescriber may adjust this based on your response and tolerability. The highest recommended dose is 200mg. It is important to take the prescribed dose and not exceed one dose in 24 hours.

Spedra works by increasing blood flow to the penile tissue through the relaxation of smooth muscles. It is a PDE-5 inhibitor with the active ingredient avanafil, which requires you to be stimulated for the medication to work effectively.

Food and drink can affect how Spedra works. Spedra can be taken with or without food, although a high-fat meal can delay the onset of activity. Spedra is taken approximately 15 to 30 minutes before sexual activity. Sexual stimulation is required for it to work.

Avoid grapefruit juice 24 hours before taking Spedra as it can increase medication levels and side effects. Drinking alcohol may lower your blood pressure further and increase side effects such as dizziness and headache, and it can reduce the medication's effectiveness.

Tell your prescriber about your medical conditions, particularly heart, blood pressure, liver, kidney or eye problems, and all medicines you take. Some conditions and medicines can make avanafil unsuitable or require a different dose.

Spedra supports the erectile response during sexual stimulation. It does not cause a continuous erection. The fast-acting nature of Spedra tablets makes it one of the quickest onset treatments available.

If you experience serious side effects such as a severe allergic reaction, sudden decrease in vision or hearing, chest pain, or an erection lasting more than four hours (priapism), seek urgent medical treatment immediately. These symptoms require prompt attention to prevent long-term damage.

You can buy Spedra online from registered UK pharmacies through online doctor services that provide discreet service and discreet packaging. The medicine can be supplied by a registered UK pharmacy following an appropriate clinical assessment and prescription.

Herbal remedies are sometimes considered as alternative treatment options, but they lack the clinical trial evidence that Spedra and other prescription medications have. Always discuss with your healthcare provider before combining herbal remedies with prescription medication.

Clinical trials have demonstrated that Spedra is an effective treatment for erectile dysfunction, but it is not suitable for everyone. Your doctor will help determine the right treatment based on your medical history and current medications.

Spedra alongside other medications should be avoided unless advised by a doctor, as interactions can cause serious side effects including a sudden decrease in blood pressure. Never combine Spedra with nitrate medications or other PDE-5 inhibitors.

Spedra 100mg is often prescribed as a starting dose, with adjustments based on effectiveness and side effects. The dose of Spedra can be increased to 200mg or decreased to 50mg depending on individual response.

Spedra lasts long enough to cover most needs but does not cause continuous erections.

Blood flow improvement is the key mechanism behind Spedra's effectiveness, achieved through the relaxation of smooth muscles in the penile area.

Spedra avanafil is part of a medication group known as PDE-5 inhibitors, which also includes sildenafil, tadalafil, and vardenafil.

It is important to avoid drinking alcohol while taking Spedra, as alcohol can exacerbate side effects and lower your blood pressure.

Tell your prescriber if you have liver problems. Mild to moderate hepatic impairment requires treatment to start at the minimum effective dose, while severe hepatic impairment is a contraindication.

Do not consume grapefruit juice or grapefruit products within 24 hours of taking Spedra, as they can interfere with the metabolism of the medication.

If you have Peyronie's disease or another penile condition, tell your prescriber so they can assess whether treatment is appropriate for you.

Always follow the prescribed dose and do not take more Spedra than recommended, as more Spedra can increase the risk of side effects without improving effectiveness.

Key things to know

• This page publishes no ratings, star scores or testimonials. Fabricating or curating them on a prescription only medicine is neither legal nor useful.
• Avanafil 200mg improved questionnaire scores by 9.4 points against 2.9 for placebo in the general population trial.
• The same strength moved the score 5.3 points in men with diabetes, compared with 8.3 points for 100mg in the general population study. Results from different study populations should not be used to predict an individual's response.
• Only 21.5% of men (153 of 712) took avanafil for at least 52 weeks in the extension study.
• Just 2.8% stopped because of an adverse event. Most who stopped, stopped for other reasons.
• NICE reports an analysis finding avanafil less effective than three other medicines in its class on one measure. Details below.
• Every trial was funded by the companies that developed the medicine.
• Do not take it with another erectile dysfunction medicine.

Why this page publishes evidence instead of Spedra 200mg reviews

Spedra 200mg is a prescription only medicine, and choosing one on the strength of other people's accounts is the wrong way to decide.

There is a specific reason for this medicine rather than a general one. Response depends heavily on why you have erectile dysfunction. The same 200mg dose moved the questionnaire score by 9.4 points in one trial population and 5.3 in another. A strong account from someone whose underlying cause differs from yours tells you very little about your own likely result, and a poor one tells you just as little.

There is also a legal point. Prescription-only medicines must not be advertised to the public. For that reason, this page does not use customer testimonials or star ratings as a way of promoting Spedra.

What replaces it here is the published data, with the population, the participant numbers and the placebo comparison attached, plus the parts of that data that do not flatter the medicine.

Searches for a Spedra 200 mg review, Spedra 200 reviews, avanafil 200mg reviews, an avanafil 200mg review or reviews on 200 mg Spedra all land on the same problem. Spedra is the brand and avanafil is the active ingredient, so they describe one medicine. Whichever phrasing you used, what exists in the UK is regulator summarised trial evidence rather than a body of verified patient ratings.

People searching for Spedra 200mg reviews are often looking for personal experiences, but those accounts cannot provide the controlled evidence needed to judge how well the medicine works.

A Spedra 200mg honest review, if the phrase means anything, has to include the findings that go against the medicine. Two of them are on this page: the indirect comparison in which avanafil came off worse, and the proportion of men who were no longer taking it after a year.

Start Your Free Assessment

Does Spedra 200mg work? What the trials actually measured

Yes, avanafil 200mg outperformed placebo on the primary measure in every trial NICE summarises, and the size of the effect varied substantially by population.

The evidence comes from three 12 week randomised controlled trials with 1,334 participants between them, plus a 52 week extension in 712 men. Response was measured with the IIEF, which NICE describes as "a 15-item questionnaire, self-administered measure of erectile function". The figures below are the change in the erectile function domain score from the start of each study.

Three things stand out, and only one of them is the obvious one.

The medicine clearly beat placebo. In the general population the gap between placebo and 200mg was 6.5 points. That is a real effect, measured against a control group, not a marketing claim.

The placebo group improved too. Scores rose 2.9 points on a dummy tablet in the general population and 1.8 points in the diabetes group. Some of what people attribute to any treatment in this area happens without an active medicine, which is exactly why uncontrolled personal accounts are unreliable.

The results differed between study populations. 200mg in men with diabetes moved the score less than 100mg did in the general population study. This shows why results from different populations should not be used to predict how an individual will respond to a particular strength.

Spedra 200mg success rate: what can and cannot be said

There is no single published success rate for Spedra 200mg, and any page giving you one number is oversimplifying. What exists is a set of average score changes in defined populations, which is a different thing.

Here is why the distinction matters. A success rate implies a yes or no outcome per person. The trials measured a continuous score across a group. An average change of 9.4 points does not mean everyone improved by 9.4 points. Some improved more, some less, and some not at all.

In the 52-week extension study, the mean IIEF erectile-function score increased by 10.3 points across the overall efficacy population.

What is not published, in the sources this page uses, is a breakdown of how many men did not respond at all. That gap is real and this page will not fill it with an invented figure. If you see a specific responder percentage for Spedra 200mg quoted without a source, treat it with suspicion.

How effective is Spedra 200mg for you specifically is not answerable from trial averages. It depends on the cause, your other conditions, your other medicines, and how you respond. Treatment suitability depends on an individual clinical assessment, and results vary between individuals.

Start Your Free Assessment

What happened over 52 weeks: the figure reviews never mention

In a 52-week extension study, 21.5% of men (153 of 712) took avanafil for at least 52 weeks, although the mean treatment duration was 35.3 weeks.

Read those three numbers together, because separately each one misleads.

Most men who stopped did not stop because it made them unwell. Adverse events accounted for under a tenth of all discontinuations. The other discontinuations were attributed to reasons such as loss to follow-up, protocol noncompliance and withdrawal of consent.

In the shorter trials, dropout ran at similar levels for reasons unrelated to the medicine. NICE records 14.9% discontinuing in the general population study, "primarily due to lack of compliance with the protocol (8.2%) or loss to follow-up (3.4%)". The diabetes study lost 14.6%, and the post prostatectomy study 15.4%, largely to withdrawal of consent and loss to follow-up.

Why this is the most honest thing on the page: it is the closest published equivalent to what a review section is really asking. Not "did it work once", but "did people keep using it". The answer is that a minority did, and side effects were rarely the reason they did not.

Spedra 200mg vs Viagra reviews: the comparison NICE actually reports

There are no head to head trials comparing avanafil with the other medicines in its class, but NICE does report an analysis that compared them indirectly, and avanafil came off worse on one measure.

This is the finding most pages leave out, so here it is in full.

NICE states that a systematic review and meta-analysis found that, compared with sildenafil, tadalafil and vardenafil, avanafil was "statistically significantly less effective on Global Assessment Questionnaire question 1", which asks: "Has the treatment you are taking improved your erectile function?"

Three caveats belong with that, and all three are important.

It is an indirect comparison, not a head to head trial. NICE separately states that "it is not known how avanafil compares to other PDE5 inhibitors" and that "there are no direct head-to-head comparisons". A meta-analysis pooling separate studies is weaker evidence than a trial designed to compare.

Start Your Free Assessment

It concerns one question on one measure. The finding relates to a single global question, not to the IIEF domain scores set out above.

It does not mean the medicine does not work. Every trial showed avanafil beating placebo. The finding is about relative position within a class, not about whether it is effective.

We are publishing it anyway, because a page called reviews that only reports the flattering findings is not a review of anything. If you are weighing Spedra against other options, this belongs in the decision. Avanafil also has a licensed dosing instruction of approximately 15 to 30 minutes before sexual activity.

No medicine in this class can be called better than another as a general statement, and the choice is a clinical one. Your prescriber will determine the appropriate treatment.

Why Spedra must never be taken with another ED medicine

Do not take Spedra with another erectile dysfunction medicine. The UK product information states that the safety and efficacy of combining avanafil with other PDE5 inhibitors or other erectile dysfunction treatments have not been studied, and patients should be advised not to use them together.

This is important if you are changing from one ED treatment to another. If Spedra has not worked as expected, speak to your prescriber rather than adding another medicine yourself.

The product information does not establish a general safe interval for combining Spedra with another PDE5 inhibitor or ED treatment. Treatment changes should therefore be discussed with the prescriber.

Who was actually studied, and who paid for it

The trial results describe a specific group of men, and they were funded by parties with a commercial interest in the outcome. Both facts belong on a page about whether to believe the evidence.

Funding. NICE records that all of the studies were funded by the companies involved in developing avanafil. That does not make the results wrong, and the trials were placebo controlled and published. It is still useful context when assessing the evidence, because all of the studies in the NICE evidence summary were funded by companies involved in developing avanafil.

Who took part? NICE notes that "the majority of men included in the 4 studies were white (80-86%), which limits the generalisability of the results to other races". That is NICE's own caveat, not this page's.

Age. Participants averaged around 56 to 58 years old, and NICE states that "limited data are available in older men aged 70 years or above".

Some groups were never studied at all. NICE states plainly that "avanafil has not been evaluated in men with erectile dysfunction due to spinal cord injury or other neurological disorders".

What that adds up to: the figures on this page are sound for the population that was studied and less certain the further you are from it. That is how evidence works, and a page claiming the results apply universally is overstating them.

Spedra 200mg experience and feedback: why forum accounts mislead

Personal accounts of Spedra 200mg vary enormously, and the trial data explains why rather than contradicting it.

People search for spedra 200mg experience, spedra 200mg feedback, spedra 200mg patient reviews and spedra 200mg forum threads because they want to know what it is actually like. That is a reasonable thing to want. The problem is what an unmoderated account cannot tell you.

Four things are missing from every anonymous account:

• Why that person had the condition. Different study populations have shown different average responses.
• What else they were taking. Interactions and contraindications change everything.
• Whether they took it as prescribed, at the licensed timing, with or without food and alcohol.
• Whether the tablet was genuine. MHRA seized more than 4 million doses of illegally traded erectile dysfunction treatments in 2025 alone.

There is a second problem, and it is a safety one. Unmoderated discussion of these medicines routinely includes combining two of them, splitting or doubling tablets, and sourcing without a prescription. Those practices can be unsafe and should not replace appropriate prescribing and clinical advice.

What is worth taking from those searches is the questions people are asking. Timing, food, alcohol, why it worked once and not another time, whether a higher strength would help. Those are all good consultation questions, and a prescriber can answer them against your actual history rather than someone else's.

Start Your Free Assessment

Spedra 200mg side effects: what was reported in the trials

NICE lists the most common adverse events for avanafil as headache, flushing, and nasal and sinus congestion, all with an incidence between 1 in 10 and 1 in 100, plus back pain between 1 in 100 and 1 in 1000. Those figures come from clinical studies with 2,144 participants.

One result runs against expectation. In the general population trial, adverse events were reported by 42.2% of the 100mg group and 38.9% of the 200mg group, and the 200mg group had the fewest discontinuations of any group including placebo. In the diabetes trial the figures were 35.4% and 32.1%. The pattern reversed after prostate surgery, at 38.4% and 45.5%.

Side effects with avanafil are therefore not simply proportional to strength, though these are differences between groups of roughly 160 men rather than a demonstrated dose response.

These adverse effects are consistent with the vasodilatory effects of PDE5 inhibition. Headache, flushing, and nasal or sinus congestion are recognised adverse effects of avanafil.

Red flags: when to seek urgent help

Seek urgent medical attention if any of the following happen after taking avanafil:

• An erection lasting more than four hours, known as priapism, whether or not it is painful
• Sudden loss of vision in one or both eyes
• Sudden loss of hearing, with or without ringing or dizziness
• Chest pain, especially during or shortly after exertion
• Fainting, or dizziness severe enough to make you fall
• Signs of an allergic reaction, including swelling of the face, lips or throat, or difficulty breathing

Do not take a nitrate for chest pain after taking avanafil unless a medical professional specifically directs you to do so. Tell the medical team what you have taken and when, because avanafil can significantly increase the blood-pressure-lowering effect of nitrates.

Speak to your prescriber, without urgency, if the medicine consistently does not work as expected, if side effects persist, or if you want to discuss whether something else would suit you better. Do not resolve any of those by taking more, or by adding something else.

To discuss whether treatment is appropriate for you, view the erectile dysfunction treatments available and complete an online consultation with UK registered prescribers, or see the Spedra tablets product page for the licensed strengths. EveryDayMeds is a GPhC registered pharmacy, and clinical assessment happens before supply.

Medical Disclaimer

This article is general information and does not replace personalised medical advice. It gives no dosing instructions and should not be used to self diagnose, self prescribe, self medicate, or to start, stop or change any medicine.

Avanafil is a prescription only medicine. Suitability depends on an individual clinical assessment by an appropriately qualified prescriber, who will consider your medical history, current medicines and cardiovascular health. This medicine should only be used under the supervision of an appropriately qualified prescriber. Results vary between individuals.

No customer reviews, ratings, star scores, testimonials or review counts appear on this page, and none should be inferred from it. Every figure quoted is a published trial result, not a report of any individual's experience.

Trial figures describe average changes across defined study populations over defined periods. They are not predictions for any individual. The comparison between strengths comes from groups within the same studies rather than from trials designed to rank them, and the comparison with other medicines in the class comes from an indirect analysis rather than a head to head trial.

The information here is not a complete account of avanafil, and the patient information leaflet supplied with your medicine is the authoritative document.

Never take more than the prescribed amount of any medicine, never take an extra tablet because the first dose did not appear to work, and do not combine Spedra with another erectile dysfunction medicine unless specifically advised by a healthcare professional.

If you experience chest pain, an erection lasting more than four hours, sudden vision loss or sudden hearing loss, seek urgent medical attention.